C
AMED

Cerebellum’s Amedisys AMED Stock Holding History

Cerebellum’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$65K Buy
+276
New +$62.8K 0.3% 54
2019
Q2 		– Sell
-2,746
Closed -$338K – 425
2019
Q1 		$338K Buy
2,746
+2,560
+1,376% +$321K 0.29% 78
2018
Q4 		$22K Buy
+186
New +$21.9K 0.02% 403

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cerebellum's AMED Position: Q3 2020 in Review

Cerebellum opened a new position in Amedisys (AMED) in Q3 2020: 276 shares worth $65K. The stake represents 0.3% of the portfolio and ranks #54 among its holdings. This is a return to the name: Cerebellum previously reported a position in AMED as recently as Q1 2019.

Cerebellum first reported a position in AMED in Q4 2018 and has held it in 3 quarters since. The position peaked at $338K in Q1 2019. 398 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Cerebellum held 276 shares of Amedisys worth $65K as of Q3 2020.
  • Amedisys was a new Cerebellum position in Q3 2020.
  • Amedisys made up 0.3% of Cerebellum's portfolio in Q3 2020, its #54 holding.
  • Cerebellum first reported a position in Amedisys in Q4 2018 and has held it in 3 quarters since.
  • Cerebellum's Amedisys position peaked at $338K in Q1 2019.
  • 398 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.